Neurocrine Biosciences | NBIX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 444.6B 59.91B 2026-06
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
ALKERMES USD 8.73B 2.85B 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 195.44B 5.55B 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Cytokinetics USD 11.55B 3.36B 2026-06
Enanta Pharmaceuticals USD 122M 98M 2024-12
Exelixis USD 13.54B 2.65B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Incyte USD 22.65B 3.92B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Prothena USD 516M 2M 2026-03
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Repligen USD 7.7B 1.05B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06